back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-13 13:35 Tx date 2025-06-13 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 12% Unsecured Convertible Debenture
38 - Redemption, retraction, cancellation, repurchase
|
$
-$100 vol $1,050 each |
$0 | |
| Filed 2025-06-13 13:34 Tx date 2025-06-13 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 12% Unsecured Convertible Debenture
38 - Redemption, retraction, cancellation, repurchase
|
$
-$100 vol $1,000 each |
||
| Filed 2025-06-13 13:30 Tx date 2025-06-13 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 12% Unsecured Convertible Debenture
38 - Redemption, retraction, cancellation, repurchase
|
$
-$100 vol $1,050 each |
$0 | |
| Filed 2025-06-13 13:29 Tx date 2025-06-13 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 12% Unsecured Convertible Debenture
38 - Redemption, retraction, cancellation, repurchase
|
$
-$100 vol $1,000 each |
||
| Filed 2025-06-13 13:22 Tx date 2025-06-13 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 12% Unsecured Convertible Debenture
38 - Redemption, retraction, cancellation, repurchase
|
$
-$100 vol $1,000 each |
||
| Filed 2025-06-13 13:18 Tx date 2025-06-13 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 12% Unsecured Convertible Debenture
38 - Redemption, retraction, cancellation, repurchase
|
$
-$100 vol $1,000 each |
||
| Filed 2025-06-13 12:34 Tx date 2025-06-13 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 12% Unsecured Convertible Debenture
38 - Redemption, retraction, cancellation, repurchase
|
-$115 vol |
$0 | |
| Filed 2025-05-05 10:18 Tx date 2025-05-02 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$10,836
+135,462 vol $0.08 each |
206,384 | |
| Filed 2025-05-05 10:17 Tx date 2025-05-02 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-135,462 vol |
0 | |
| Filed 2025-05-05 10:16 Tx date 2025-05-02 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$17,066
+213,333 vol $0.08 each |
599,831 | |
| Filed 2025-05-05 10:15 Tx date 2025-05-02 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-213,333 vol |
0 | |
| Filed 2025-05-05 10:13 Tx date 2025-05-02 |
$WLLW
Willow Biosciences Inc. |
Asadorian, Raffi
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$17,066
+213,333 vol $0.08 each |
220,000 | |
| Filed 2025-05-05 10:12 Tx date 2025-05-02 |
$WLLW
Willow Biosciences Inc. |
Asadorian, Raffi
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-213,333 vol |
0 | |
| Filed 2025-05-05 10:10 Tx date 2025-05-02 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$10,836
+135,462 vol $0.08 each |
2,003,797 | |
| Filed 2025-05-05 10:09 Tx date 2025-05-02 |
$WLLW
Willow Biosciences Inc. |
Archibald, Donald
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-135,462 vol |
0 | |
| Filed 2025-05-03 15:10 Tx date 2025-05-02 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+537,161 vol |
2,083,445 | |
| Filed 2025-05-03 15:09 Tx date 2025-05-02 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
36 - Conversion or exchange
|
-537,161 vol |
0 | |
| Filed 2025-05-03 15:07 Tx date 2025-05-02 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
58 - Expiration of rights
|
-137,455 vol |
0 | |
| Filed 2024-09-13 17:17 Tx date 2024-09-13 |
$WLLW
Willow Biosciences Inc. |
Lalonde, James Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+275,000 vol |
475,000 | |
| Filed 2024-09-13 17:14 Tx date 2024-09-13 |
$WLLW
Willow Biosciences Inc. |
Asadorian, Raffi
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+275,000 vol |
475,000 |